In a 65-year-old man with exertional dyspnea, syncope, a harsh midsystolic murmur at the right upper sternal border radiating to the carotid arteries, cardiomegaly on chest X‑ray, and left ventricular hypertrophy on ECG, what is the most appropriate management?

Surgical Aortic Valve Replacement is the Most Appropriate Management

This 65-year-old man with symptomatic severe aortic stenosis (exertional dyspnea and syncope) requires urgent surgical or transcatheter aortic valve replacement—medical management with antihypertensives, vasodilators, or diuretics is contraindicated and potentially harmful. The answer is B. Surgical valvular replacement.

Clinical Diagnosis: Symptomatic Severe Aortic Stenosis

The clinical presentation is classic for severe aortic stenosis:

• Symptoms: Progressive exertional dyspnea with syncope (the "classic triad" includes dyspnea, angina, and syncope) 1
• Physical exam: Mid-systolic murmur at right upper sternal border radiating to carotids—pathognomonic for aortic stenosis 1, 2
• ECG: Left ventricular hypertrophy—indicates chronic pressure overload 1
• Chest X-ray: Cardiomegaly—reflects compensatory LV changes

Once symptoms develop in severe aortic stenosis, prognosis deteriorates rapidly 1. This patient has crossed from asymptomatic (Stage C) to symptomatic severe AS (Stage D), which fundamentally changes management.

Why Valve Replacement is Mandatory

Guideline-Based Recommendations

Patients with severe AS and any valve-related symptoms (dyspnea, syncope, angina) should undergo valve replacement (Class I, Level B recommendation) 1. This is the highest level of recommendation in cardiology guidelines.

The 2024 AHA/ACC guidelines explicitly state that symptomatic patients require intervention, with the choice between surgical AVR (SAVR) or transcatheter AVR (TAVR) based primarily on surgical risk 3. The 2017 ACC/AHA appropriate use criteria confirm that intervention is "Appropriate" for all symptomatic patients with severe AS 4.

Evidence Supporting Urgent Intervention

Studies demonstrate dramatic differences in outcomes:

• 30-day mortality: 4.3% in untreated symptomatic severe AS vs. 0% in those who underwent AVR before surgery 3
• Perioperative MACE: 20.5% in untreated AS vs. 5.4% in those with prior AVR (P<0.001) 3

Symptomatic patients require urgent surgery—medical treatment for heart failure is reserved only for non-operable patients 1.

Why Medical Management Options Are Wrong and Dangerous

Option A: Antihypertensives - CONTRAINDICATED

Tight blood pressure control with antihypertensives can precipitate hemodynamic collapse in severe AS. The fixed obstruction prevents increased cardiac output, and aggressive BP lowering reduces coronary perfusion pressure, potentially causing syncope or sudden death.

Option C: Vasodilators - CONTRAINDICATED

Vasodilators are particularly dangerous in severe AS. The stenotic valve creates a fixed afterload that cannot accommodate vasodilation-induced preload reduction. This can cause:

• Severe hypotension
• Decreased coronary perfusion
• Syncope or cardiac arrest

Option D: Diuretics - INADEQUATE and POTENTIALLY HARMFUL

While diuretics may temporarily relieve pulmonary congestion, they:

• Do not address the underlying mechanical obstruction
• Can reduce preload excessively, decreasing cardiac output
• Provide only symptomatic palliation without survival benefit
• Are appropriate only for non-operable patients as bridge therapy 1

Neither statin treatment nor any other medical treatment has been shown to retard progression of AS 1.

Clinical Decision Algorithm

For this patient:

1. Confirm severe AS with echocardiography (valve area <1.0 cm², mean gradient ≥40 mmHg, or peak velocity ≥4.0 m/s) 3, 5

2. Assess surgical risk using STS-PROM score:

   • Low-intermediate risk: SAVR is standard of care
   • High risk: TAVR is reasonable alternative 3, 4
   • Prohibitive risk: TAVR is recommended 6

3. Evaluate LV function:

   • If LVEF <50%: Still proceed with intervention (Class I indication) 1
   • Dobutamine stress echo may help assess contractile reserve in low-gradient cases 5

4. Proceed urgently: Symptomatic severe AS requires intervention without delay—the patient is at high risk for sudden death 1, 7

Critical Pitfalls to Avoid

• Never delay intervention in symptomatic severe AS to "optimize" with medical therapy
• Never use vasodilators or aggressive diuresis as primary management
• Do not mistake LVH for hypertensive heart disease—the murmur and clinical context indicate valvular pathology
• Avoid assuming the patient needs "medical optimization" before referral—this delays life-saving intervention

Immediate Next Steps

1. Urgent cardiology referral for valve intervention planning 7
2. Echocardiography to quantify AS severity and assess LV function 5, 8
3. Multidisciplinary heart valve team evaluation for SAVR vs. TAVR decision 3
4. Avoid all negative inotropes, vasodilators, and aggressive diuresis pending intervention

The only appropriate management is valve replacement (surgical or transcatheter)—all medical management options listed are either inadequate or contraindicated.